glp-1 in obesity Simplified summary of the biological actions of GIP and as GLP-1 Weight Regain Is Not

The trial enrolled 76 children with severe IGFD and followed them for up to 8 years on twice-daily subcutaneous mecasermin administration, with growth velocity, height standard-deviation score, and adverse events as primary endpoints

And it doesnt have to be intense

"Theres also reason to believe with lifestyle improvement which includes better sleep, eating better and exercise you might wind up in a healthier state than just weight loss with the medications." If lifestyle modification doesnt work and parents are interested, he sometimes prescribes medication

Now, Sean, with the Fed moving toward rate cuts, how do you see this impacting your sector on the biotech side